retatrutide blindness Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide: The triple-action peptide revolutionizing

Ultimately, the success of your work hinges on controlling variables

To explore how well GLP-1R agonists access various parts of the brain, Sechers team labeled various agonists with fluorescent tags so that when they administered the agonists to mice, they could see which areas of their brains lit up

GLP-1 drugs remain GLP-1 drugs

And without trial data: 1) Insurance (probably) wont cover it

Doctors will check: Blood sugar levels, usually every few months, to track how well diabetes is controlled Kidney function, especially in people with diabetes or those who may be at risk for dehydration Weight and blood pressure, to monitor progress and overall health Eye exams, especially for people with diabetes, to watch for any changes in vision Signs of pancreatitis, gallbladder problems, or allergic reactions, especially if new symptoms appear People taking other diabetes medicines may need extra monitoring for low blood sugar